Skip to main content
Embecta Corp. (EMBC)
NASDAQ: EMBC · Real-Time Price · USD
14.01
+0.40 (2.94%)
Nov 21, 2024, 1:07 PM EST - Market open

Embecta Revenue

Embecta had revenue of $272.50M in the quarter ending June 30, 2024, a decrease of -4.75%. This brings the company's revenue in the last twelve months to $1.12B, up 0.48% year-over-year. In the fiscal year ending September 30, 2023, Embecta had annual revenue of $1.12B, down -0.77%.

Revenue (ttm)
$1.12B
Revenue Growth
+0.48%
P/S Ratio
0.70
Revenue / Employee
$508,591
Employees
2,200
Market Cap
808.40M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 20231.12B-8.70M-0.77%
Sep 30, 20221.13B-35.80M-3.07%
Sep 30, 20211.17B79.80M7.35%
Sep 30, 20201.09B-23.50M-2.12%
Sep 30, 20191.11B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Pacira BioSciences 694.96M
Avanos Medical 681.50M
Bioventus 555.06M
Evolus 248.33M
Avid Bioservices 142.36M
Cronos Group 111.23M
Autolus Therapeutics 10.09M
Revenue Rankings

EMBC News

More News